Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the Eyebrows
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The overall purpose of this study is to evaluate the safety and effectiveness of repeat
treatment of an intramuscular dose of Mentor Purified Toxin for the reduction of frown lines,
compared with placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Mentor Worldwide, LLC
Collaborator:
Synteract, Inc.
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA